This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Kansai Medical University, Zeria Pharmaceutical Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 11 
1 out of 45 Years Active: 2008
Title: Junichi Fujisawa: Innovator in Antibody Research
Introduction
Junichi Fujisawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies.
Latest Patents
Fujisawa holds a patent for "Antibodies specific for phosphorylation sites and screening methods using the same antibodies." This includes a polyclonal antibody specific for a phosphorylated linker region in Smad2 and/or Smad3. His work in this area has implications for understanding cellular signaling pathways.
Career Highlights
Throughout his career, Fujisawa has worked with prominent organizations such as Zeria Pharmaceutical Co., Ltd. and Kansai Medical University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Fujisawa has collaborated with notable colleagues, including Koichi Matsuzaki and Toshihito Seki. These partnerships have enriched his research endeavors and fostered innovation in his field.
Conclusion
Junichi Fujisawa's work in antibody research exemplifies the impact of innovative thinking in biotechnology. His contributions continue to influence the scientific landscape and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile